Cathay Capital has launched Cathay Health, a new €500 million global fund dedicated to investing at the convergence of healthcare, life sciences and technology.
Building on the success of the firm’s investment track record and platform, the new fund will focus on venture to growth-stage companies across Europe, North America and Asia.
Cathay Health represents the latest expansion of Cathay Capital, which has invested nearly €500 million in the healthcare sector to date across 34 companies on three continents from its private equity and venture funds. C
Cathay Health is backed by leading institutional and corporate investors such as French public investment bank Bpifrance, global insurance company AXA and pharmaceutical company Groupe Pierre Fabre. It has also received the label from the Tibi Commission, which aims to accelerate the financing of French and European technology companies to create global leaders.
